Nighttime Synchrony of Your Nutrition and Circadian Health
N-Sync
1 other identifier
interventional
120
1 country
1
Brief Summary
Sleep is an important factor for overall health. This study will see how different light exposure patterns and food intake impact a person's metabolism (how the body breaks down food) when sleeping is reduced. Participants will attend 6 to 8 in-person visits to the study clinic, including three overnight stays. People will complete surveys and medical tests. The study will last about 4 to 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2025
CompletedStudy Start
First participant enrolled
December 19, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2031
January 22, 2026
January 1, 2026
4.4 years
December 11, 2025
January 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Insulin Sensitivity
Insulin sensitivity will be measured by intravenous glucose tolerance tests.
Immediately following the 5-day sleep restriction segment
Internal Circadian Misalignment (Uridine and Isobutyryl-L-carnitine)
Phase angle between DLMO and acrophase of uridine and isobutyryl-L-carnitine during constant routine.
During the constant routine, following the 5-day sleep restriction segment
Other Outcomes (2)
Timing of DLMO and DLMOff
During the constant routine, following the 5-day sleep restriction segment
Hunger and Satiety Visual Analog Scales
During the constant routine, following the 5-day sleep restriction segment
Study Arms (3)
Sleep Restriction with Central and Peripheral Alignment
NO INTERVENTION(Arm "A")-Control condition with central and peripheral aligned circadian rhythms
Sleep Restriction with Central Clock Misalignment
EXPERIMENTAL(Arm "B")-Misalignment of the central clock by nighttime electrical light exposure and dim-light in morning hours.
Sleep Restriction with Peripheral Misalignment
EXPERIMENTAL(Arm "C")-Misalignment of peripheral oscillators by shifting the majority of food intake to the nighttime hours.
Interventions
Light exposure will be dimmed during the first 4 hours of scheduled wakefulness, with bright light exposure during the nighttime hours of extended wakefulness.
Most daily calories will be given later in the day to shift eating patterns toward the nighttime hours.
Eligibility Criteria
You may qualify if:
- Age: 18-35 years old; equal numbers of men and women
- Body Mass Index (BMI): 18.5-24.9 kg/m2
- Sleep Habits: habitual self-reported average total sleep time (TST) 7-9 hours per night for prior 6 months
You may not qualify if:
- Clinically diagnosed sleep disorder or apnea hypopnea index (AHI) ≥5
- Evidence of significant organ system dysfunction or disease (e.g., heart disease, diabetes)
- Fasting plasma glucose ≥100 mg/dL
- Major psychiatric illness (e.g., major depressive disorder)
- Cancer that has been in remission less than 5 years
- History of shift-work in prior year
- Weight change \>5% of body weight over prior six months
- Currently following a weight-loss program
- Menopause
- Pregnant/nursing
- Greater than 5-day variation in menstrual cycle length month-to-month
- Currently smoking
- Alcohol intake \>14 drinks/week or \>3 drinks/day.
- Use of prescription medications (except oral contraceptives) within one month prior to or during in-lab visits.
- Consumption of illegal drugs or \>500mg per day of caffeine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Health Research Complex - University of Utah, Salt Lake City 84112
Salt Lake City, Utah, 84112, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher Depner, PhD
University of Utah
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Randomization to condition order will be concealed to research staff and participants until the conclusion of the condition "A", which all participants will complete first.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
December 11, 2025
First Posted
January 9, 2026
Study Start
December 19, 2025
Primary Completion (Estimated)
May 31, 2030
Study Completion (Estimated)
May 31, 2031
Last Updated
January 22, 2026
Record last verified: 2026-01